Cargando…

Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP

BACKGROUND: Infants with unilateral brain lesions are at high risk of developing unilateral cerebral palsy (CP). Given the great plasticity of the young brain, possible interventions for infants at risk of unilateral CP deserve exploration. Constraint-induced movement therapy (CIMT) is known to be e...

Descripción completa

Detalles Bibliográficos
Autores principales: Eliasson, Ann-Christin, Sjöstrand, Lena, Ek, Linda, Krumlinde-Sundholm, Lena, Tedroff, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062504/
https://www.ncbi.nlm.nih.gov/pubmed/24903062
http://dx.doi.org/10.1186/1471-2431-14-141
_version_ 1782321663602327552
author Eliasson, Ann-Christin
Sjöstrand, Lena
Ek, Linda
Krumlinde-Sundholm, Lena
Tedroff, Kristina
author_facet Eliasson, Ann-Christin
Sjöstrand, Lena
Ek, Linda
Krumlinde-Sundholm, Lena
Tedroff, Kristina
author_sort Eliasson, Ann-Christin
collection PubMed
description BACKGROUND: Infants with unilateral brain lesions are at high risk of developing unilateral cerebral palsy (CP). Given the great plasticity of the young brain, possible interventions for infants at risk of unilateral CP deserve exploration. Constraint-induced movement therapy (CIMT) is known to be effective for older children with unilateral CP but is not systematically used for infants. The development of CIMT for infants (baby-CIMT) is described here, as is the methodology of an RCT comparing the effects on manual ability development of baby-CIMT versus baby-massage. The main hypothesis is that infants receiving baby-CIMT will develop manual ability in the involved hand faster than will infants receiving baby-massage in the first year of life. METHOD AND DESIGN: The study will be a randomised, controlled, prospective parallel-group trial. Invited infants will be to be randomised to either the baby-CIMT or the baby-massage group if they: 1) are at risk of developing unilateral CP due to a known neonatal event affecting the brain or 2) have been referred to Astrid Lindgren Children’s Hospital due to asymmetric hand function. The inclusion criteria are age 3–8 months and established asymmetric hand use. Infants in both groups will receive two 6-weeks training periods separated by a 6-week pause, for 12 weeks in total of treatment. The primary outcome measure will be the new Hand Assessment for Infants (HAI) for evaluating manual ability. In addition, the Parenting Sense of Competence scale and Alberta Infant Motor Scale will be used. Clinical neuroimaging will be utilized to characterise the brain lesion type. To compare outcomes between treatment groups generalised linear models will be used. DISCUSSION: The model of early intensive intervention for hand function, baby-CIMT evaluated by the Hand Assessment for Infants (HAI) will have the potential to significantly increase our understanding of how early intervention of upper limb function in infants at risk of developing unilateral CP can be performed and measured. TRIAL REGISTRATION: SFO-V4072/2012, 05/22/2013
format Online
Article
Text
id pubmed-4062504
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40625042014-06-19 Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP Eliasson, Ann-Christin Sjöstrand, Lena Ek, Linda Krumlinde-Sundholm, Lena Tedroff, Kristina BMC Pediatr Study Protocol BACKGROUND: Infants with unilateral brain lesions are at high risk of developing unilateral cerebral palsy (CP). Given the great plasticity of the young brain, possible interventions for infants at risk of unilateral CP deserve exploration. Constraint-induced movement therapy (CIMT) is known to be effective for older children with unilateral CP but is not systematically used for infants. The development of CIMT for infants (baby-CIMT) is described here, as is the methodology of an RCT comparing the effects on manual ability development of baby-CIMT versus baby-massage. The main hypothesis is that infants receiving baby-CIMT will develop manual ability in the involved hand faster than will infants receiving baby-massage in the first year of life. METHOD AND DESIGN: The study will be a randomised, controlled, prospective parallel-group trial. Invited infants will be to be randomised to either the baby-CIMT or the baby-massage group if they: 1) are at risk of developing unilateral CP due to a known neonatal event affecting the brain or 2) have been referred to Astrid Lindgren Children’s Hospital due to asymmetric hand function. The inclusion criteria are age 3–8 months and established asymmetric hand use. Infants in both groups will receive two 6-weeks training periods separated by a 6-week pause, for 12 weeks in total of treatment. The primary outcome measure will be the new Hand Assessment for Infants (HAI) for evaluating manual ability. In addition, the Parenting Sense of Competence scale and Alberta Infant Motor Scale will be used. Clinical neuroimaging will be utilized to characterise the brain lesion type. To compare outcomes between treatment groups generalised linear models will be used. DISCUSSION: The model of early intensive intervention for hand function, baby-CIMT evaluated by the Hand Assessment for Infants (HAI) will have the potential to significantly increase our understanding of how early intervention of upper limb function in infants at risk of developing unilateral CP can be performed and measured. TRIAL REGISTRATION: SFO-V4072/2012, 05/22/2013 BioMed Central 2014-06-05 /pmc/articles/PMC4062504/ /pubmed/24903062 http://dx.doi.org/10.1186/1471-2431-14-141 Text en Copyright © 2014 Eliasson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Eliasson, Ann-Christin
Sjöstrand, Lena
Ek, Linda
Krumlinde-Sundholm, Lena
Tedroff, Kristina
Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP
title Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP
title_full Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP
title_fullStr Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP
title_full_unstemmed Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP
title_short Efficacy of baby-CIMT: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral CP
title_sort efficacy of baby-cimt: study protocol for a randomised controlled trial on infants below age 12 months, with clinical signs of unilateral cp
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062504/
https://www.ncbi.nlm.nih.gov/pubmed/24903062
http://dx.doi.org/10.1186/1471-2431-14-141
work_keys_str_mv AT eliassonannchristin efficacyofbabycimtstudyprotocolforarandomisedcontrolledtrialoninfantsbelowage12monthswithclinicalsignsofunilateralcp
AT sjostrandlena efficacyofbabycimtstudyprotocolforarandomisedcontrolledtrialoninfantsbelowage12monthswithclinicalsignsofunilateralcp
AT eklinda efficacyofbabycimtstudyprotocolforarandomisedcontrolledtrialoninfantsbelowage12monthswithclinicalsignsofunilateralcp
AT krumlindesundholmlena efficacyofbabycimtstudyprotocolforarandomisedcontrolledtrialoninfantsbelowage12monthswithclinicalsignsofunilateralcp
AT tedroffkristina efficacyofbabycimtstudyprotocolforarandomisedcontrolledtrialoninfantsbelowage12monthswithclinicalsignsofunilateralcp